Mylan (MYL) Affirms Favorable USPTO Ruling to Invalidate Two Teva Patents Covering Copaxone
Go back to Mylan (MYL) Affirms Favorable USPTO Ruling to Invalidate Two Teva Patents Covering Copaxone| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 13.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.25 | 52 Week High | $66.55 | |||
| Open | $13.25 | 52 Week Low | $37.82 | |||
| Day High | $13.25 | P/E | N/A | |||
| Day Low | $13.25 | EPS | $0.00 | |||
| Volume | 596 | |||||
